A study to determine clinical effectiveness and safety of a second entry DPI – dry powder inhaler (Salflumix Easyhaler) in patients with asthma in everyday clinical practice
Latest Information Update: 14 Apr 2023
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 14 Apr 2023 New trial record
- 01 Apr 2023 According to results published in the Journal of Asthma, Zbigniew Doniec, Magdalena Olszanecka-Glinianowicz, and Agnieszka Almgren-Rachtan. EUROMEDIC Medical Center represented by Agnieszka Almgren Rachtan was the study organizer responsible for data collecting, management, and providing the study.
- 01 Apr 2023 Results published in the Journal of Asthma